News
Keep up with Ology Bioservices. Here’s our latest…
News
Ology Bioservices, Inovio Partner To Manufacture COVID-19 DNA Vaccine With $11.9 Million Department of Defense Grant
Ology Bioservices, Inovio Partner To Manufacture COVID-19 DNA Vaccine With $11.9 Million Department of Defense Grant
Ology Bioservices, Vanderbilt University Medical Center to Develop, Manufacture Monoconal Antibody for Treatment, Prevention of Infection With COVID-19 Virus for Department of Defense
Ology Bioservices, Vanderbilt University Medical Center to Develop, Manufacture Monoconal Antibody for Treatment, Prevention of Infection With COVID-19 Virus for Department of Defense...
Government Contracts for Biodefense
Government Contracts For Biodefense: The Benefits and Risks. Robert V. House, PhD, FATS, Senior Vice President of Government Contracts at Ology Bioservices shares his thoughts on the benefits of Government Contracting in [...]
CEPI awards up to US$43.6 million to Public Health Vaccines, LLC. for development of a single-dose Nipah virus vaccine candidate
CEPI awards up to US$43.6 million to Public Health Vaccines, LLC. for development of a single-dose Nipah virus vaccine candidate Public Health Vaccine, LLC. will partner with Crozet Biopharma to develop the Nipah [...]
Blue Water Vaccines, Developing Universal Flu Vaccine, to Partner With Ology Bioservices Inc.
Blue Water Vaccines, Developing Universal Flu Vaccine, to Partner With Ology Bioservices Inc. PRESS RELEASE UPDATED: AUG 7, 2019 CINCINNATI, August 7, 2019 (Newswire.com) - Blue Water Vaccines, a Cincinnati-based biotechnology startup, [...]
Monoclonal Antibody Combinations Prevent Serotype A and Serotype B Inhalational Botulism in a Guinea Pig Model
Tomic MT, Espinoza Y, Martinez Z, et al. Monoclonal Antibody Combinations Prevent Serotype A and Serotype B Inhalational Botulism in a Guinea Pig Model. Toxins 2019, 11(4), 208; https://doi.org/10.3390/toxins11040208. Read More > [...]
COVID-19 Letter